The marfan syndrome an echocardiographic study

Marfan's syndrome was first reported by a French Dr. Marfan in 1896. It is an inherited generalised disorder of connective tissue with ocular; skeletal and cardiovascular manifestations. There is wide variability and clinical expression. The prevalence of disorder has been estimated to be more than 1 in 50 000; perhaps 1 in 10 000 persons. This text finalement is a report about marfan's syndrome in Seychelles

A study of the effect of nifedipine in reversing left ventricular hypertrophy in hypertensive patients

Using WHO hypertensive criteria; 184 patients with hypertension were chosen (102 male; 82 female); aged 58-78 years old. Other heart diseases were ruled out by physical examination; electrocardiographic examination; chest-ray and echocardiography. All the cases had one or more criteria of left ventricular hypertrophy (LVH): Interventricular septal thickness at diastole; left ventricular posterior wall thickness at end diastole and left ventricular mass index. The findings in this study imply that it is good practise to include nifedipine in the treatment regimen of patients whose hypertension is complicated with LVH and (or) ischaemic heart disease